MenFive is a meningococcal (A, C, Y, W, X) polysaccharide conjugate vaccine by Serum Institute of India (SII).
MenFive is indicated for the active immunization of individuals aged 1-85 years against invasive meningococcal disease caused by Neisseria meningitidis groups A, C, Y, W, and X.
MenFive is administered through intramuscular (IM) injection only, preferably in the deltoid muscle. In children below 5 years of age, the anterolateral aspect of the thigh may be used as an alternate site if injection in the deltoid muscle is not feasible.
The MenFive vaccination course consists of a single dose of 0.5 ml.
Your email address will not be published. Required fields are marked *